Leerink Partners Raised Price Target on Globus Medical (GMED) Following Preliminary 4Q Results

January 7, 2016 7:20 AM

Leerink Partners reiterated an Outperform rating on Globus Medical (NYSE: GMED), and raised the price target to $32.00 (from $31.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found